IBOGF stock -
I suspect IBOGF is in the very early stages of being something huge. And is only .037 right now
Based on April 2026 reports, Universal Ibogaine Inc. (ticker: IBOGF) is positioned within a sector expected to benefit from new Trump administration policies aimed at accelerating research into psychedelic treatments, particularly for mental health issues facing veterans.
Key Developments (April 2026):
Executive Order: President Trump signed an executive order, "Accelerating Medical Treatments for Serious Mental Illness," directing the FDA to expedite reviews of psychedelics, including ibogaine.
Federal Funding: The administration announced a $50 million investment in research into ibogaine and other psychedelic therapies.
Sector Impact: Following the news, shares of multiple psychedelic drug developers surged, and the broader, AdvisorShares Psychedelics ETF (PSIL) advanced, reflecting investor optimism for companies involved in this sector.
Veterans' Focus: The policy is heavily focused on using ibogaine to treat PTSD and addiction in combat veterans.